Cancer

Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate

Exclusive Option Agreement to Acquire Orphan Drug Candidate for Behçet's DiseaseNovel therapeutic with Fast Track and Orphan DesignationLONDON, UK /…

2 years ago

Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #acquisition--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive…

2 years ago

Cosmo Has Received Approval of an Extension in Respect of the Publication and the Filing of Its Annual Report 2023

Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - April 29, 2024) - Cosmo Pharmaceuticals N.V. (SIX:…

2 years ago

Sona’s Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model

Halifax, Nova Scotia--(Newsfile Corp. - April 29, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")…

2 years ago

Community Impact: Unite Iowa Adds 12,500 Programs to Unite Us Platform to Increase Access to Vital Community Resources

The state's leading coordinated care network, operated by CyncHealth Iowa, celebrates a milestone year serving Iowa residents using Unite Us'…

2 years ago

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

Next safety cohort to begin escalated dosing soonOCALA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American:…

2 years ago

SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study

– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3…

2 years ago

Verspeeten Family Cancer Centre Unveiling Marks a Historic Milestone in Cancer Research and Treatment

LONDON, Ontario, April 29, 2024 (GLOBE NEWSWIRE) -- London Health Sciences Foundation (LHSF) is proud to announce the unveiling of…

2 years ago

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Dubai Healthcare Authority Granted Insurance Reimbursement for Biomerica’s EZ Detect™ Colon Disease Screening Test EZ Detect™ is a simple FDA…

2 years ago